Quick Answer
Q32 Bio Inc. reported Earnings Per Share Diluted of $2.42 per share for the year ending 2025.
- Q32 Bio Inc. showed an increase of +136.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Q32 Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.02 (loss) per share | Q2 2021: $0.54 (loss) per share | Q3 2021: $0.54 (loss) per share | Q1 2022: $1.59 per share | Q2 2022: $0.51 (loss) per share | Q3 2022: $0.59 (loss) per share | Q1 2023: $19.84 (loss) per share | Q2 2023: $16.69 (loss) per share | Q3 2023: $40.52 (loss) per share | Q1 2024: $6.33 (loss) per share | Q2 2024: $1.42 (loss) per share | Q3 2024: $1.46 (loss) per share | Q1 2025: $0.90 (loss) per share | Q2 2025: $0.78 (loss) per share | Q3 2025: $0.60 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Q32 Bio Inc.'s Earnings Per Share Diluted has grown by 239.9%.
- Historical annual values: Fiscal year 2025: $2.42 per share | Fiscal year 2024: $6.58 (loss) per share | Fiscal year 2023: $153.96 (loss) per share | Fiscal year 2022: $0.09 (loss) per share | Fiscal year 2021: $1.73 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: